Endogenous mouse mammary tumor viruses (Mtv): New roles for an old virus in cancer, infection, and immunity

Frontiers in Oncology

Volumn 3 NOV, Issue , 2013, Pages

  Holt, Michael P ^a   Shevach, Ethan M ^a   Punkosdy, George A ^a,b  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer; Endogenous retrovirus; Immune system; Infection; Mouse mammary tumor virus

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; SUPERANTIGEN; T LYMPHOCYTE RECEPTOR;

CELL SELECTION; ENDOGENOUS MOUSE MAMMARY TUMOR VIRUS; ENDOGENOUS RETROVIRUS; EXOGENOUS MOUSE MAMMARY TUMOR VIRUS; HUMAN; IMMUNE RESPONSE; IMMUNITY; IMMUNOMODULATION; INFECTION; NEOPLASM; NONHUMAN; REGULATORY T LYMPHOCYTE; RETROVIRUS INFECTION; REVIEW; T LYMPHOCYTE RECEPTOR GENE; TUMOR IMMUNITY; VIRUS EXPRESSION;

EID: 84891080538     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2013.00287     Document Type: Review

References (91)

1. Tristem M. Identification and characterization of novel human endogenous retrovirus families by phylogenetic screening of the human genome mapping project database. J Virol (2000) 74(8):3715-30. doi: 10.1128/JVI.74.8.3715-3730.2000
2. Polavarapu N, Bowen NJ, McDonald JF. Identification, characterization and comparative genomics of chimpanzee endogenous retroviruses. Genome Biol (2006) 7(6):R51. doi:10.1186/gb-2006-7-6-r51
3. Huda A, Polavarapu N, Jordan IK, McDonald JF. Endogenous retroviruses of the chicken genome. Biol Direct (2008) 3:9. doi:10.1186/1745-6150-3-9
4. Stocking C, Kozak CA. Murine endogenous retroviruses. Cell Mol Life Sci (2008) 65(21):3383-98. doi:10.1007/s00018-008-8497-0
5. Kozak C, Peters G, Pauley R, Morris V, Michalides R, Dudley J, et al. A standardized nomenclature for endogenous mouse mammary tumor viruses. J Virol (1987) 61(5):1651-4.
6. Karapetian O, Shakhov AN, Kraehenbuhl JP, Acha-Orbea H. Retroviral infection of neonatal Peyer's patch lymphocytes: the mouse mammary tumor virus model. J Exp Med (1994) 180(4):1511-6. doi:10.1084/jem.180.4.1511
7. Hook LM, Agafonova Y, Ross SR, Turner SJ, Golovkina TV. Genetics of mouse mammary tumor virus-induced mammary tumors: linkage of tumor induction to the gag gene. J Virol (2000) 74(19):8876-83. doi:10.1128/JVI.74.19.8876-8883.2000
8. Lee BK, Eicher EM. Segregation patterns of endogenous mouse mammary tumor viruses in five recombinant inbred strain sets. J Virol (1990) 64(9):4568-72.
9. Morris VL, Medeiros E, Ringold GM, Bishop JM, Varmus HE. Comparison of mouse mammary tumor virus-specific DNA in inbred, wild and Asian mice, and in tumors and normal organs from inbred mice. J Mol Biol (1977) 114(1):73-91. doi:10.1016/0022-2836(77)90284-4
10. van Nie R, Verstraeten AA. Studies of genetic transmission of mammary tumour virus by C3Hf mice. Int J Cancer (1975) 16(6):922-31. doi:10.1002/ijc.2910160606
11. Michalides R, van Deemter L, Nuss RR, van Nie R. Identification of the Mtv-2 gene responsible for the early appearance of mammary tumors in the GR mouse by nucleic acid hybridization. Proc Natl Acad Sci U S A (1978) 75(5):2368-72. doi:10.1073/pnas.75.5.2368
12. Michalides R, van Nie R, Nusse R, Hynes NE, Groner B. Mammary tumor induction loci in GR and DBAf mice contain one provirus of the mouse mammary tumor virus. Cell (1981) 23(1):165-73. doi:10.1016/0092-8674(81)90281-6
13. Ross SR. MMTV infectious cycle and the contribution of virus-encoded proteins to transformation of mammary tissue. J Mammary Gland Biol Neoplasia (2008) 13(3):299-307. doi:10.1007/s10911-008-9090-8
14. Acha-Orbea H, Shakhov AN, Scarpellino L, Kolb E, Muller V, Vessaz-Shaw A, et al. Clonal deletion of V beta 14-bearing T cells in mice transgenic for mammary tumour virus. Nature (1991) 350(6315):207-11. doi:10.1038/350207a0
15. Choi Y, Kappler JW, Marrack P. A superantigen encoded in the open reading frame of the 3' long terminal repeat of mouse mammary tumour virus. Nature (1991) 350(6315):203-7. doi:10.1038/350203a0
16. Mertz JA, Lozano MM, Dudley JP. Rev and Rex proteins of human complex retroviruses function with the MMTV Rem-responsive element. Retrovirology (2009) 6:10. doi:10.1186/1742-4690-6-10
17. Indik S, Gunzburg WH, Salmons B, Rouault F. A novel, mouse mammary tumor virus encoded protein with Rev-like properties. Virology (2005) 337(1):1-6. doi:10.1016/j.virol.2005.03.040
18. Mertz JA, Simper MS, Lozano MM, Payne SM, Dudley JP. Mouse mammary tumor virus encodes a self-regulatory RNA export protein and is a complex retrovirus. J Virol (2005) 79(23):14737-47. doi:10.1128/JVI.79.23.14737-14747.2005
19. Salmons B, Knedlitschek G, Kennedy N, Groner B, Ponta H. The endogenous mouse mammary tumour virus locus Mtv-8 contains a defective envelope gene. Virus Res (1986) 4(4):377-89. doi:10.1016/0168-1702(86)90084-5
20. Kuo WL, Vilander LR, Huang M, Peterson DO. A transcriptionally defective long terminal repeat within an endogenous copy of mouse mammary tumor virus proviral DNA. J Virol (1988) 62(7):2394-402.
21. Cho K, Ferrick DA, Morris DW. Structure and biological activity of the subgenomic Mtv-6 endogenous provirus. Virology (1995) 206(1):395-402. doi:10.1016/S0042-6822(95)80055-7
22. Bittner JJ. Some possible effects of nursing on the mammary gland tumor incidence in mice. Science (1936) 84(2172):162. doi:10.1126/science.84.2172.162
23. Bittner JJ. The milk-influence of breast tumors in mice. Science (1942) 95(2470):462-3. doi:10.1126/science.95.2470.462
24. Beutner U, Kraus E, Kitamura D, Rajewsky K, Huber BT. B cells are essential for murine mammary tumor virus transmission, but not for presentation of endogenous superantigens. J Exp Med (1994) 179(5):1457-66. doi:10.1084/jem.179.5.1457
25. Rassa JC, Meyers JL, Zhang Y, Kudaravalli R, Ross SR. Murine retroviruses activate B cells via interaction with toll-like receptor 4. Proc Natl Acad Sci U S A (2002) 99(4):2281-6. doi:10.1073/pnas.042355399
26. Golovkina TV, Chervonsky A, Dudley JP, Ross SR. Transgenic mouse mammary tumor virus superantigen expression prevents viral infection. Cell (1992) 69(4):637-45. doi:10.1016/0092-8674(92)90227-4
27. Pullen AM, Wade T, Marrack P, Kappler JW. Identification of the region of T cell receptor beta chain that interacts with the self-superantigen MIs-1a. Cell (1990) 61(7):1365-74. doi:10.1016/0092-8674(90)90700-O
28. Acha-Orbea H, Scarpellino L, Shakhov AN, Held W, MacDonald HR. Inhibition of mouse mammary tumor virus-induced T cell responses in vivo by antibodies to an open reading frame protein. J Exp Med (1992) 176(6):1769-72. doi:10.1084/jem.176.6.1769
29. Yazdanbakhsh K, Park CG, Winslow GM, Choi Y. Direct evidence for the role of COOH terminus of mouse mammary tumor virus superantigen in determining T cell receptor V beta specificity. J Exp Med (1993) 178(2):737-41. doi:10.1084/jem.178.2.737
30. Maillard I, Erny K, Acha-Orbea H, Diggelmann H. A V beta 4-specific superantigen encoded by a new exogenous mouse mammary tumor virus. Eur J Immunol (1996) 26(5):1000-6. doi:10.1002/eji.1830260507
31. Chervonsky AV, Xu J, Barlow AK, Khery M, Flavell RA, Janeway CA Jr. Direct physical interaction involving CD40 ligand on T cells and CD40 on B cells is required to propagate MMTV. Immunity (1995) 3(1):139-46. doi:10.1016/1074-7613(95)90166-3
32. Held W, Shakhov AN, Izui S, Waanders GA, Scarpellino L, MacDonald HR, et al. Superantigen-reactive CD4+ T cells are required to stimulate B cells after infection with mouse mammary tumor virus. J Exp Med (1993) 177(2):359-66. doi:10.1084/jem.177.2.359
33. Tsubura A, Inaba M, Imai S, Murakami A, Oyaizu N, Yasumizu R, et al. Intervention of T-cells in transportation of mouse mammary tumor virus (milk factor) to mammary gland cells in vivo. Cancer Res (1988) 48(22):6555-9.
34. Squartini F, Olivi M, Bolis GB. Mouse strain and breeding stimulation as factors influencing the effect of thymectomy on mammary tumorigenesis. Cancer Res (1970) 30(7):2069-72.
35. Wrona T, Dudley JP. Major histocompatibility complex class II I-E-independent transmission of C3H mouse mammary tumor virus. J Virol (1996) 70(2):1246-9.
36. Nusse R, Varmus HE. Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. Cell (1982) 31(1):99-109. doi:10.1016/0092-8674(82)90409-3
37. Dickson C, Peters G. Potential oncogene product related to growth factors. Nature (1987) 326(6116):833. doi:10.1038/326833a0
38. Faschinger A, Rouault F, Sollner J, Lukas A, Salmons B, Gunzburg WH, et al. Mouse mammary tumor virus integration site selection in human and mouse genomes. J Virol (2008) 82(3):1360-7. doi:10.1128/JVI.02098-07
39. Dickson C, Smith R, Brookes S, Peters G. Tumorigenesis by mouse mammary tumor virus: proviral activation of a cellular gene in the common integration region int-2. Cell (1984) 37(2):529-36. doi:10.1016/0092-8674(84)90383-0
40. Nusse R, van Ooyen A, Cox D, Fung YK, Varmus H. Mode of proviral activation of a putative mammary oncogene (int-1) on mouse chromosome 15. Nature (1984) 307(5947):131-6. doi:10.1038/307131a0
41. Peters G, Brookes S, Smith R, Placzek M, Dickson C. The mouse homolog of the hst/k-FGF gene is adjacent to int-2 and is activated by proviral insertion in some virally induced mammary tumors. Proc Natl Acad Sci U S A (1989) 86(15):5678-82. doi:10.1073/pnas.86.15.5678
42. Festenstein H. Immunogenetic and biological aspects of in vitro lymphocyte allotransformation (MLR) in the mouse. Transplant Rev (1973) 15:62-88.
43. Woodland D, Happ MP, Bill J, Palmer E. Requirement for cotolerogenic gene products in the clonal deletion of I-E reactive T cells. Science (1990) 247(4945):964-7. doi:10.1126/science.1968289
44. Dyson PJ, Knight AM, Fairchild S, Simpson E, Tomonari K. Genes encoding ligands for deletion of V beta 11 T cells cosegregate with mammary tumour virus genomes. Nature (1991) 349(6309):531-2. doi:10.1038/349531a0
45. Frankel WN, Rudy C, Coffin JM, Huber BT. Linkage of Mls genes to endogenous mammary tumour viruses of inbred mice. Nature (1991) 349(6309):526-8. doi:10.1038/349526a0
46. Woodland DL, Happ MP, Gollob KJ, Palmer E. An endogenous retrovirus mediating deletion of alpha beta T cells? Nature (1991) 349(6309):529-30. doi:10.1038/349529a0
47. Kappler JW, Roehm N, Marrack P. T cell tolerance by clonal elimination in the thymus. Cell (1987) 49(2):273-80. doi:10.1016/0092-8674(87)90568-X
48. Marrack P, Kushnir E, Kappler J. A maternally inherited superantigen encoded by a mammary tumour virus. Nature (1991) 349(6309):524-6. doi:10.1038/349524a0
49. Kappler JW, Wade T, White J, Kushnir E, Blackman M, Bill J, et al. A T cell receptor V beta segment that imparts reactivity to a class II major histocompatibility complex product. Cell (1987) 49(2):263-71. doi:10.1016/0092-8674(87)90567-8
50. Beutner U, Frankel WN, Cote MS, Coffin JM, Huber BT. Mls-1 is encoded by the long terminal repeat open reading frame of the mouse mammary tumor provirus Mtv-7. Proc Natl Acad Sci U S A (1992) 89(12):5432-6. doi:10.1073/pnas.89.12.5432
51. Winslow GM, Scherer MT, Kappler JW, Marrack P. Detection and biochemical characterization of the mouse mammary tumor virus 7 superantigen (Mls-1a). Cell (1992) 71(5):719-30. doi:10.1016/0092-8674(92)90549-R
52. Scherer MT, Ignatowicz L, Pullen A, Kappler J, Marrack P. The use of mammary tumor virus (Mtv)-negative and single-Mtv mice to evaluate the effects of endogenous viral superantigens on the T cell repertoire. J Exp Med (1995) 182(5):1493-504. doi:10.1084/jem.182.5.1493
53. Acha-Orbea H, Held W, Waanders GA, Shakhov AN, Scarpellino L, Lees RK, et al. Exogenous and endogenous mouse mammary tumor virus superantigens. Immunol Rev (1993) 131:5-25. doi:10.1111/j.1600-065X.1993.tb01527.x
54. Scherer MT, Ignatowicz L, Winslow GM, Kappler JW, Marrack P. Superantigens: bacterial and viral proteins that manipulate the immune system. Annu Rev Cell Biol (1993) 9:101-28. doi:10.1146/annurev.cb.09.110193.000533
55. Golovkina TV, Prescott JA, Ross SR. Mouse mammary tumor virus-induced tumorigenesis in sag transgenic mice: a laboratory model of natural selection. J Virol (1993) 67(12):7690-4.
56. van Nie R, de Moes J. Development of a congeneic line of the GR mouse strain without early mammary tumours. Int J Cancer (1977) 20(4):588-94. doi:10.1002/ijc.2910200417
57. Dawe CJ, Freund R, Mandel G, Ballmer-Hofer K, Talmage DA, Benjamin TL. Variations in polyoma virus genotype in relation to tumor induction in mice. Characterization of wild type strains with widely differing tumor profiles. Am J Pathol (1987) 127(2):243-61.
58. Freund R, Dubensky T, Bronson R, Sotnikov A, Carroll J, Benjamin T. Polyoma tumorigenesis in mice: evidence for dominant resistance and dominant susceptibility genes of the host. Virology (1992) 191(2):724-31. doi:10.1016/0042-6822(92)90248-N
59. Lukacher AE, Ma Y, Carroll JP, Abromson-Leeman SR, Laning JC, Dorf ME, et al. Susceptibility to tumors induced by polyoma virus is conferred by an endogenous mouse mammary tumor virus superantigen. J Exp Med (1995) 181(5):1683-92. doi:10.1084/jem.181.5.1683
60. Lukacher AE, Freund R, Carroll JP, Bronson RT, Benjamin TL. Pyvs: a dominantly acting gene in C3H/BiDa mice conferring susceptibility to tumor induction by polyoma virus. Virology (1993) 196(1):241-8. doi:10.1006/viro.1993.1472
61. Velupillai P, Sung CK, Andrews E, Moran J, Beier D, Kagan J, et al. Polymorphisms in toll-like receptor 4 underlie susceptibility to tumor induction by the mouse polyomavirus. J Virol (2012) 86(21):11541-7. doi:10.1128/JVI.01614-12
62. Lukacher AE, Wilson CS. Resistance to polyoma virus-induced tumors correlates with CTL recognition of an immunodominant H-2Dk-restricted epitope in the middle T protein. J Immunol (1998) 160(4):1724-34.
63. Schirrmacher V, Beutner U, Bucur M, Umansky V, Rocha M, von Hoegen P. Loss of endogenous mouse mammary tumor virus superantigen increases tumor resistance. J Immunol (1998) 161(2):563-70.
64. Schirrmacher V, Zangemeisterwittke U. Gamma-irradiation suppresses T-cell mediated protective immunity against a metastatic tumor in the afferent phase of the immune-response but enhances it in the efferent phase when given before immune cell transfer. Int J Oncol (1994) 4(2):335-46.
65. Bosslet K, Schirrmacher V. Escape of metastasizing clonal tumor cell variants from tumor-specific cytolytic T lymphocytes. J Exp Med (1981) 154(2):557-62. doi:10.1084/jem.154.2.557
66. Schirrmacher V, Muerkoster S, Bucur M, Umansky V, Rocha M. Breaking tolerance to a tumor-associated viral superantigen as a basis for graft-versus-leukemia reactivity. Int J Cancer (2000) 87(5):695-706. doi:10.1002/1097-0215(20000901)87:5<695::AID-IJC12>3.0.CO;2-B
67. Lasky JL, Ponzio NM, Thorbecke GJ. Characterization and growth factor requirements of SJL lymphomas. I. Development of a B cell growth factor-dependent in vitro cell line, cRCS-X. J Immunol (1988) 140(2):679-87.
68. Lasky JL, Thorbecke GJ. Characterization and growth factor requirements of SJL lymphomas. II. Interleukin 5 dependence of the in vitro cell line, cRCS-X, and influence of other cytokines. Eur J Immunol (1989) 19(2):365-71. doi:10.1002/eji.1830190222
69. Ponzio NM, Chapman-Alexander J, Thorbecke GJ. Properties of reticulum cell sarcomas in SJL/J mice VI. Characterization of lymphoid cells that proliferate in response to RCS cells. Cell Immunol (1978) 41(1):157-71. doi:10.1016/S0008-8749(78)80035-5
70. Tsiagbe VK, Asakawa J, Miranda A, Sutherland RM, Paterson Y, Thorbecke GJ. Syngeneic response to SJL follicular center B cell lymphoma (reticular cell sarcoma) cells is primarily in V beta 16+ CD4+ T cells. J Immunol (1993) 150(12):5519-28.
71. Sen N, Simmons WJ, Thomas RM, Erianne G, Zhang DJ, Jaeggli NS, et al. META-controlled env-initiated transcripts encoding superantigens of murine Mtv29 and Mtv7 and their possible role in B cell lymphomagenesis. J Immunol (2001) 166(9):5422-9.
72. Bhadra S, Lozano MM, Payne SM, Dudley JP. Endogenous MMTV proviruses induce susceptibility to both viral and bacterial pathogens. PLoS Pathog (2006) 2(12):e128. doi:10.1371/journal.ppat.0020128
73. Purdy A, Case L, Duvall M, Overstrom-Coleman M, Monnier N, Chervonsky A, et al. Unique resistance of I/LnJ mice to a retrovirus is due to sustained interferon gamma-dependent production of virus-neutralizing antibodies. J Exp Med (2003) 197(2):233-43. doi:10.1084/jem.20021499
74. Mustafa F, Bhadra S, Johnston D, Lozano M, Dudley JP. The type B leukemogenic virus truncated superantigen is dispensable for T-cell lymphomagenesis. J Virol (2003) 77(6):3866-70. doi:10.1128/JVI.77.6.3866-3870.2003
75. Held W, Shakhov AN, Waanders G, Scarpellino L, Luethy R, Kraehenbuhl JP, et al. An exogenous mouse mammary tumor virus with properties of Mls-1a (Mtv-7). J Exp Med (1992) 175(6):1623-33. doi:10.1084/jem.175.6.1623
76. Bhadra S, Lozano MM, Dudley JP. BALB/Mtv-null mice responding to strong mouse mammary tumor virus superantigens restrict mammary tumorigenesis. J Virol (2009) 83(1):484-8. doi:10.1128/JVI.01374-08
77. Reiner SL, Locksley RM. The regulation of immunity to Leishmania major. Annu Rev Immunol (1995) 13:151-77. doi:10.1146/annurev.iy.13.040195.001055
78. Varanasi V, Mattoo H, Tupperwar NC, Thyagarajan K, Das A, Kumar R, et al. A superantigen interacts with leishmanial infection in antigen-presenting cells to regulate cytokine commitment of responding CD4 T cells. J Infect Dis (2010) 202(8):1234-45. doi:10.1086/656366
79. Grau GE, Piguet PF, Engers HD, Louis JA, Vassalli P, Lambert PH. L3T4+ T lymphocytes play a major role in the pathogenesis of murine cerebral malaria. J Immunol (1986) 137(7):2348-54.
80. Hermsen C, van de Wiel T, Mommers E, Sauerwein R, Eling W. Depletion of CD4+ or CD8+ T-cells prevents Plasmodium berghei induced cerebral malaria in end-stage disease. Parasitology (1997) 114(Pt 1):7-12. doi:10.1017/S0031182096008293
81. Grau GE, Fajardo LF, Piguet PF, Allet B, Lambert PH, Vassalli P. Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria. Science (1987) 237(4819):1210-2. doi:10.1126/science.3306918
82. Grau GE, Heremans H, Piguet PF, Pointaire P, Lambert PH, Billiau A, et al. Monoclonal antibody against interferon gamma can prevent experimental cerebral malaria and its associated overproduction of tumor necrosis factor. Proc Natl Acad Sci U S A (1989) 86(14):5572-4. doi:10.1073/pnas.86.14.5572
83. Boubou MI, Collette A, Voegtle D, Mazier D, Cazenave PA, Pied S. T cell response in malaria pathogenesis: selective increase in T cells carrying the TCR V(beta)8 during experimental cerebral malaria. Int Immunol (1999) 11(9):1553-62. doi:10.1093/intimm/11.9.1553
84. Gorgette O, Existe A, Boubou MI, Bagot S, Guenet JL, Mazier D, et al. Deletion of T cells bearing the V beta8.1 T-cell receptor following mouse mammary tumor virus 7 integration confers resistance to murine cerebral malaria. Infect Immun (2002) 70(7):3701-6. doi:10.1128/IAI.70.7.3701-3706.2002
85. Matloubian M, Concepcion RJ, Ahmed R. CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection. J Virol (1994) 68(12):8056-63.
86. Wherry EJ, Blattman JN, Murali-Krishna K, van der Most R, Ahmed R. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J Virol (2003) 77(8):4911-27. doi:10.1128/JVI.77.8.4911-4927.2003
87. Punkosdy GA, Blain M, Glass DD, Lozano MM, O'Mara L, Dudley JP, et al. Regulatory T-cell expansion during chronic viral infection is dependent on endogenous retroviral superantigens. Proc Natl Acad Sci U S A (2011) 108(9):3677-82. doi:10.1073/pnas.1100213108
88. Van Elven EH, Rolink AG, Veen FV, Gleichmann E. Capacity of genetically different T lymphocytes to induce lethal graft-versus-host disease correlates with their capacity to generate suppression but not with their capacity to generate anti-F1 killer cells. A non-H-2 locus determines the inability to induce lethal graft-versus-host disease. J Exp Med (1981) 153(6):1474-88.
89. Allen RD, Slayback DL, Harper JM, Aguirre TL, Dobkins JA. A locus closely linked to Mtv7 on mouse chromosome 1 influences development of acute versus chronic graft-versus-host disease in a murine model. Clin Immunol (2000) 95(1 Pt 1):9-19. doi:10.1006/clim.2000.4841
90. Suerth JD, Schambach A, Baum C. Genetic modification of lymphocytes by retrovirus-based vectors. Curr Opin Immunol (2012) 24(5):598-608. doi:10.1016/j.coi.2012.08.007
91. Sun J, Zhao L, Teng L, Lin F, Zhang H, Li Z, et al. Solid tumor-targeted infiltrating cytotoxic T lymphocytes retained by a superantigen fusion protein. PLoS One (2011) 6(2):e16642. doi:10.1371/journal.pone.0016642